Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a ...

A report details "deviations" during manufacturing of more than 135,000 packages, which could possibly contribute to other ...

Shares of Cytokinetics, which targets medicines for specialty heart diseases, have jumped about 69% over the past three months and are up 31% year to date.

Although findings from a large retrospective study supports these positive effects of taking a GLP-1, it’s unclear whether ...

A new analysis finds that the heart-protecting benefits of semaglutide are largely independent of its weight loss effects.

Novartis' blockbuster heart treatment Entresto saw sales growth stall in the third quarter of the year, dragging the Swiss ...

The drug’s effects on cardiovascular and inflammation markers outshined its failure to spur weight loss, analysts wrote.

GLP-1 drugs like Mounjaro, which were created to help type 2 diabetes patients and sometimes manage weight loss, actually ...

PHOENIX -- Use of tirzepatide (Mounjaro, Zepbound) was associated with significantly lower risks of death, hospitalization, ...

Your prescription may be involved. The FDA explains why suddenly stopping your medication is more harmful than taking it.

The use of sacubitril/valsartan appears feasible and safe in recipients of left ventricular assist devices, reducing the need ...

In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.